[go: up one dir, main page]

HN2011000745A - Sales de n-[6-cis-2,6-dimetil-morfolin-4-il)-piridin-3-il]-2-metil-4´-(triflouro-metoxi)-[1,1´-bifenil]-3-carboxamida - Google Patents

Sales de n-[6-cis-2,6-dimetil-morfolin-4-il)-piridin-3-il]-2-metil-4´-(triflouro-metoxi)-[1,1´-bifenil]-3-carboxamida

Info

Publication number
HN2011000745A
HN2011000745A HN2011000745A HN2011000745A HN2011000745A HN 2011000745 A HN2011000745 A HN 2011000745A HN 2011000745 A HN2011000745 A HN 2011000745A HN 2011000745 A HN2011000745 A HN 2011000745A HN 2011000745 A HN2011000745 A HN 2011000745A
Authority
HN
Honduras
Prior art keywords
triflouro
metoxi
carboxamide
pyridin
cis
Prior art date
Application number
HN2011000745A
Other languages
English (en)
Inventor
Joginder Sing Bajwa
La Cruz Marilyn De
Stephanie Kay Dodd
Liladhar Murlidhar Waykole
Raeann Wu
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41228716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN2011000745(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HN2011000745A publication Critical patent/HN2011000745A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PREPARAN Y SE CARACTERIZAN SALES DE N-[6-CIS-2,6-DIMETIL-MORFOLIN-4-IL)-PIRIDIN-3-IL]-2-METIL-4´-(TRIFLOURO-METOXI)-[1,1´-BIFENIL]-3-CARBOXAMIDA.
HN2011000745A 2008-09-17 2011-03-15 Sales de n-[6-cis-2,6-dimetil-morfolin-4-il)-piridin-3-il]-2-metil-4´-(triflouro-metoxi)-[1,1´-bifenil]-3-carboxamida HN2011000745A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9758008P 2008-09-17 2008-09-17

Publications (1)

Publication Number Publication Date
HN2011000745A true HN2011000745A (es) 2014-01-06

Family

ID=41228716

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2011000745A HN2011000745A (es) 2008-09-17 2011-03-15 Sales de n-[6-cis-2,6-dimetil-morfolin-4-il)-piridin-3-il]-2-metil-4´-(triflouro-metoxi)-[1,1´-bifenil]-3-carboxamida

Country Status (39)

Country Link
US (3) US8063043B2 (es)
EP (1) EP2342198B1 (es)
JP (2) JP4897938B2 (es)
KR (2) KR101129088B1 (es)
CN (1) CN102159570B (es)
AR (2) AR073591A1 (es)
AU (1) AU2009293444B2 (es)
BR (2) BRPI0918629B8 (es)
CA (1) CA2736751C (es)
CL (1) CL2011000551A1 (es)
CO (1) CO6351744A2 (es)
CR (1) CR20110126A (es)
CU (1) CU23860B1 (es)
DK (1) DK2342198T3 (es)
DO (1) DOP2011000082A (es)
EA (1) EA020048B1 (es)
EC (1) ECSP11010985A (es)
ES (1) ES2418485T3 (es)
GE (1) GEP20125592B (es)
HN (1) HN2011000745A (es)
HR (1) HRP20130597T1 (es)
IL (1) IL211412A (es)
JO (1) JO2889B1 (es)
MA (1) MA32717B1 (es)
MX (1) MX2011002805A (es)
MY (1) MY151100A (es)
NI (1) NI201100051A (es)
NZ (1) NZ591420A (es)
PE (1) PE20110292A1 (es)
PH (1) PH12012500399A1 (es)
PL (1) PL2342198T3 (es)
PT (1) PT2342198E (es)
SI (1) SI2342198T1 (es)
SM (1) SMT201300072B (es)
SV (1) SV2011003857A (es)
TW (1) TWI367883B (es)
UA (1) UA103049C2 (es)
WO (1) WO2010033481A1 (es)
ZA (1) ZA201101579B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
CN101993415B (zh) * 2010-09-15 2013-08-14 北京韩美药品有限公司 作为Hedgehog通路抑制剂的化合物以及包含该化合物的药物组合物及其应用
WO2014128661A1 (en) 2013-02-25 2014-08-28 Novartis Ag Oral formulation and suspension of an oncology drug
WO2015092720A1 (en) * 2013-12-19 2015-06-25 Novartis Ag Metabolites of sonidegib (lde225)
CN105906616B (zh) * 2015-03-30 2018-09-04 苏州晶云药物科技有限公司 Lde225单磷酸盐的晶型及其制备方法
WO2016196928A1 (en) 2015-06-04 2016-12-08 PellePharm, Inc. Topical formulations for delivery of hedgehog inhibitor compounds and use thereof
CA3017411C (en) 2016-03-15 2024-06-25 Oryzon Genomics, S.A. Combinations of lsd1 inhibitors for use in the treatment of solid tumors
WO2017163258A1 (en) * 2016-03-22 2017-09-28 Msn Laboratories Private Limited Process for the preparation of n-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2- methyl-4'-(trifiuoromethoxy) [1,1' -biphenyi]-3-carboxamide and its polymorphs thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0415022A (pt) * 2003-10-02 2006-11-28 Pharmacia & Upjohn Co Llc sais e polimorfos de um composto de indolinona substituìda com pirrol
GB0412468D0 (en) * 2004-06-04 2004-07-07 Astrazeneca Ab Chemical compounds
UA93548C2 (uk) 2006-05-05 2011-02-25 Айерем Елелсі Сполуки та композиції як модулятори хеджхогівського сигнального шляху
PE20080948A1 (es) * 2006-07-25 2008-09-10 Irm Llc Derivados de imidazol como moduladores de la senda de hedgehog

Also Published As

Publication number Publication date
SI2342198T1 (sl) 2013-07-31
HRP20130597T1 (en) 2013-07-31
CU23860B1 (es) 2013-02-26
PE20110292A1 (es) 2011-05-17
BR122020009045A2 (pt) 2020-11-10
UA103049C2 (uk) 2013-09-10
MX2011002805A (es) 2011-04-11
CN102159570A (zh) 2011-08-17
BR122020009045B1 (pt) 2022-08-02
CU20110055A7 (es) 2011-12-28
MA32717B1 (fr) 2011-10-02
TW201016686A (en) 2010-05-01
CA2736751A1 (en) 2010-03-25
AR073591A1 (es) 2010-11-17
CA2736751C (en) 2012-10-23
ZA201101579B (en) 2011-11-30
EP2342198A1 (en) 2011-07-13
JP2012097104A (ja) 2012-05-24
IL211412A0 (en) 2011-05-31
ECSP11010985A (es) 2011-05-31
SMT201300072B (it) 2013-09-06
BRPI0918629A2 (pt) 2020-10-27
KR101129088B1 (ko) 2012-03-23
JO2889B1 (en) 2015-03-15
NI201100051A (es) 2011-09-08
US20120214810A1 (en) 2012-08-23
DOP2011000082A (es) 2011-04-15
ES2418485T3 (es) 2013-08-14
AR113778A2 (es) 2020-06-10
DK2342198T3 (da) 2013-07-01
IL211412A (en) 2014-07-31
PH12012500399A1 (en) 2014-04-28
EA201100501A1 (ru) 2011-10-31
BRPI0918629B1 (pt) 2021-04-13
US8063043B2 (en) 2011-11-22
JP2012502912A (ja) 2012-02-02
US20110178085A1 (en) 2011-07-21
CO6351744A2 (es) 2011-12-20
CR20110126A (es) 2011-04-27
GEP20125592B (en) 2012-07-25
NZ591420A (en) 2012-07-27
US20120035174A1 (en) 2012-02-09
EA020048B1 (ru) 2014-08-29
KR20120015363A (ko) 2012-02-21
SV2011003857A (es) 2011-05-16
TWI367883B (en) 2012-07-11
PT2342198E (pt) 2013-07-10
EP2342198B1 (en) 2013-04-03
AU2009293444A1 (en) 2010-03-25
PL2342198T3 (pl) 2013-08-30
BRPI0918629B8 (pt) 2021-05-25
CL2011000551A1 (es) 2011-07-15
MY151100A (en) 2014-04-15
JP4897938B2 (ja) 2012-03-14
KR20110056325A (ko) 2011-05-26
HK1156628A1 (en) 2012-06-15
AU2009293444B2 (en) 2012-03-15
WO2010033481A1 (en) 2010-03-25
CN102159570B (zh) 2014-01-15

Similar Documents

Publication Publication Date Title
HN2011000745A (es) Sales de n-[6-cis-2,6-dimetil-morfolin-4-il)-piridin-3-il]-2-metil-4´-(triflouro-metoxi)-[1,1´-bifenil]-3-carboxamida
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
EA201590292A1 (ru) Соединения, которые являются sip-модулирующими агентами и/или atx-модулирующими агентами
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
EA201692272A1 (ru) Модуляторы s1p
RS54730B1 (sr) Inhibitori beta sekretaze
UA113062C2 (xx) Похідні 5-фтор-4-іміно-3-(заміщеного)-3,4-дигідропіримідин-2(1h)ону
UA116809C2 (uk) Застосування агрохімічних сумішей для збільшення життєздатності рослини
EA201400260A1 (ru) Гербицидные композиции, включающие хлорацетамиды
UY32535A (es) Métodos e intermediarios para la preparación de agentes farmacéuticos
UY34013A (es) ?compuestos de cromenona con actividad anti-tumoral?.
EA201101148A1 (ru) Новые гербициды
EA201101060A1 (ru) Новые гербициды
UY31688A1 (es) Plaguicidas
ATE490962T1 (de) Co-kristalle von propiconazol
EA201101146A1 (ru) Новые гербициды
EA201101099A1 (ru) Гербициды, полученные из циклопентадиона
MX343611B (es) Composicion de control de fitoenfermedades y su uso.
MA31985B1 (fr) (r)-2-(4-cyclopropanesulfonyl-phényl)-n-pyrazin-2-yl-3-(tétrahydropyran-4-yl)- propionamide cristallin
UY33642A (es) Formula mejorada de herbicida
UY34442A (es) 2-tiopirimidinonas.
RS54488B1 (en) NALOXOL-POLYETHYLENE GLYCOL CRYSTAL CONJUGATE
EA201270256A1 (ru) Производные т1-замещенного 5-фтор-2-оксопиримидинон-1 (2h) -карбоксамида
UA106880C2 (uk) Нові гербіциди